Session 6: Resectable Pancreatic Cancer
Chairs: Serge Evrard (France), John P. Neoptolemos (UK), Radka Obermannova (Czech Republic)
- Why is there such little chance for cure in early pancreatic cancer? (Jens Werner, Germany)
- Improving outcome: A case for neoadjuvant radiochemotherapy (Karin Haustermans, Belgium)
- Improving outcome: A case for neoadjuvant chemotherapy (Thomas T. W. Seufferlein, Germany)
Why is there such little chance for cure in early pancreatic cancer?
-
Werner Hartwig, Germany:
Improving outcome: A case for neoadjuvant radiochemotherapy
-
Karin Haustermans, Belgium:
Improving outcome: A case for neoadjuvant chemotherapy
-
Thomas T. W. Seufferlein, Germany:
Discussion Session 6: Resectable Pancreatic Cancer
Webcast: